Dietary glycine and serine restriction for cancer treatment
US12370162B1 · kind B1 · utility
0Cited by
0References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 2, 2025 |
| Grant date | Jul 29, 2025 |
| Priority date | — |
| Expiry date | Jan 2, 2045 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is a food composition that comprises a plurality of amino acids or the salts thereof, wherein the plurality of amino acids or the salts thereof comprise about 0.0016-0.6 wt % of glycine or the salt thereof and about 0.00109-1.2 wt % of serine or the salt thereof. Also provided is a method for treating cancer in a subject in need thereof, comprising partly or completely substituting or replacing the normal diet of the subject with the food composition, and optionally administering to the subject a therapeutically effective amount of an anti-PD-1 antibody or an anti-PD-Li antibody.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.